MedPath

Evaluation of the mobility assessement CHARMI® during inpatient neurological rehabilitation (phase C) in stroke patients

Conditions
stroke patients
Registration Number
DRKS00031764
Lead Sponsor
Kliniken Beelitz GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
23
Inclusion Criteria

ischaemic or haemorrhagic stroke
- patients in late neurological rehabilitation (phase C)
- first visit ( V1) within 6 weeks poststroke
- age =18 years

Exclusion Criteria

none

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
-CHARMI at admission (visit 1)<br>-Barthel Index (validity) at admission
Secondary Outcome Measures
NameTimeMethod
-CHARMI at visit 2 (re-assessment 3 weeks after admission)<br>-length of hospital stay (acute hospital, phase B, phase C)<br>-self-assessment of mobility at visit 2<br>-global cognition (MMSE) at visit 1
© Copyright 2025. All Rights Reserved by MedPath